Diuretics, mortality, and nonrecovery of renal function in acute renal failure.

By R. Mehta, M. T. Pascual, Sharon B. Soroko, Glenn M. Chertow. Journal of the American Medical Association (JAMA), 2002

599 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. (2013, background): “654 increase urine output independent of augmentation of kidney function, such as loop diuretics or dopamine, may not be helpful and may even be harmful in some settings.(25,26) While the inclusion of these criteria in the AKI guideline may have the beneficial effect of encouraging more rigorous doc”
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury (2007, background): “Recent epidemiological studies demonstrate the wide variation in etiologies and risk factors [1,5-7], describe the increased mortality associated with this disease (particularly when dialysis is required) [1,4,6,8,9], and suggest a relationship to the subsequent development of chronic kidney disease”
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) (2013, background): “Epidemiologic data suggest that the use of loop diuretics may increase mortality in patients with critical illness and AKI [58], along with confl icting data that suggest no harm in AKI [59].”
Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. (2007, unknown): “001 SBP (mmHg; mean SD ) 116 (27) 112 (24) 119 (29) 0.”